Northview Congratulates Portfolio Company Perimeter Medical Imaging AI Inc. on FDA Breakthrough Device Designation
Northview Lifesciences would like to congratulate Perimeter on their FDA Breakthrough Device Designation for the Optical Coherence Tomography (OCT) Imaging System with ImgAssist AI. The OCT Imaging System offers real time intra-operative evaluation of breast cancer tumor margins during lumpectomies and will give surgeons tomographical confirmation of cancer removal. The goal of the FDA Breakthrough Device Program is to allow timely access to effective treatment and medical devices by speeding up development, assessment, and review. This designation will potentially offer Perimeter’s medical technology a swifter development pathway from clinical validation through to the final stages of development and expedite it’s availability to market and patient use.
Northview Lifesciences – Advancing the Business of Science